Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

654 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
Parving HH, Andersen AR, Smidt UM, Svendsen PA. Parving HH, et al. Lancet. 1983 May 28;1(8335):1175-9. doi: 10.1016/s0140-6736(83)92462-5. Lancet. 1983. PMID: 6133986
Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment.
Sato A, Tarnow L, Nielsen FS, Knudsen E, Parving HH. Sato A, et al. Among authors: parving hh. QJM. 2005 Dec;98(12):879-84. doi: 10.1093/qjmed/hci137. Epub 2005 Nov 4. QJM. 2005. PMID: 16272208
Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
Andrésdóttir G, Bakker SJ, Hansen HP, Parving HH, Rossing P. Andrésdóttir G, et al. Among authors: parving hh. Diabet Med. 2013 May;30(5):563-6. doi: 10.1111/dme.12131. Epub 2013 Mar 7. Diabet Med. 2013. PMID: 23324103 Clinical Trial.
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM. Jorsal A, et al. Among authors: parving hh. Diabetologia. 2008 Nov;51(11):2100-7. doi: 10.1007/s00125-008-1123-8. Epub 2008 Aug 22. Diabetologia. 2008. PMID: 18719882
Long-term prevention of diabetic nephropathy: an audit.
Schjoedt KJ, Hansen HP, Tarnow L, Rossing P, Parving HH. Schjoedt KJ, et al. Among authors: parving hh. Diabetologia. 2008 Jun;51(6):956-61. doi: 10.1007/s00125-008-0990-3. Epub 2008 Apr 3. Diabetologia. 2008. PMID: 18385971
Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients.
Lajer M, Schjoedt KJ, Jacobsen P, Tarnow L, Parving HH. Lajer M, et al. Among authors: parving hh. Diabet Med. 2006 Jun;23(6):675-80. doi: 10.1111/j.1464-5491.2006.01871.x. Diabet Med. 2006. PMID: 16759311
Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH. Schjoedt KJ, et al. Among authors: parving hh. Scand J Clin Lab Invest. 2006;66(3):173-80. doi: 10.1080/00365510600548702. Scand J Clin Lab Invest. 2006. PMID: 16714246 Clinical Trial.
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH. Schjoedt KJ, et al. Among authors: parving hh. Diabetologia. 2004 Nov;47(11):1936-9. doi: 10.1007/s00125-004-1542-0. Epub 2004 Nov 17. Diabetologia. 2004. PMID: 15551047 Clinical Trial.
Birth weight--a risk factor for progression in diabetic nephropathy?
Jacobsen P, Rossing P, Tarnow L, Hovind P, Parving HH. Jacobsen P, et al. Among authors: parving hh. J Intern Med. 2003 Mar;253(3):343-50. doi: 10.1046/j.1365-2796.2003.01109.x. J Intern Med. 2003. PMID: 12603502
Pregnancy and progression of diabetic nephropathy.
Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, Parving HH. Rossing K, et al. Among authors: parving hh. Diabetologia. 2002 Jan;45(1):36-41. doi: 10.1007/s125-002-8242-4. Diabetologia. 2002. PMID: 11845221
654 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page